Notice of Public Hearing: NIAID Proposed Reorganization

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services National Institutes of Health AGENCY: National Institutes of Health, HHS. ACTION: Notice. SUMMARY: Pursuant to the NIH Reform Act of 2006 ( 42 U.S.C. 281(d)(4) ), notice is hereby given that the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) will be accepting comments on a proposed reorganization involving the Division of Clinical Research (DCR). DATES: Comments regarding this proposed reorganization are best assured of having their full effect if received from September 14th, 2026-September 18th, 2026. ADDRESSES: Information on the proposed reorganization can be found at: https://www.niaid.nih.gov/​about/​niaid-organization-DCR . The following email address is being provided for comments on the reorganization NIAIDExecutiveServices@mail.nih.gov . The Website will be active September 14th through September 18th, 2026. FOR FURTHER INFORMATION CONTACT: For additional questions about this proposed reorganization contact: Katherine Beck, Acting Executive Officer, National Institute of Allergy and Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20892. SUPPLEMENTARY INFORMATION: NIAID's proposal to implement organizational changes involving the Division of Clinical Research (DCR). The goal for the reorganization is to abolish several offices and the Division of Clinical Research (DCR) and realign the clinical operations and oversight across multiple NIAID components. …